Chandra Bhagat Pharma's quarterly market cap
declined
from Sep. 2022 (₹802 Mil) to Mar. 2023 (₹732 Mil) but then
increased
from Mar. 2023 (₹732 Mil) to Sep. 2023 (₹830 Mil).
Chandra Bhagat Pharma's annual market cap
increased
from Mar. 2021 (₹299 Mil) to Mar. 2022 (₹859 Mil) but then
declined
from Mar. 2022 (₹859 Mil) to Mar. 2023 (₹732 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Chandra Bhagat Pharma's Enterprise Value for Today is ₹1,073 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Chandra Bhagat Pharma's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Chandra Bhagat Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chandra Bhagat Pharma's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Chandra Bhagat Pharma's Market Cap distribution charts can be found below:
* The bar in red indicates where Chandra Bhagat Pharma's Market Cap falls into.
Chandra Bhagat Pharma Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Chandra Bhagat Pharma's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chandra Bhagat Pharma (BOM:542934) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Chandra Bhagat Pharma Market Cap Related Terms
Thank you for viewing the detailed overview of Chandra Bhagat Pharma's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Chandra Bhagat Pharma (BOM:542934) Business Description
Chandra Bhagat Pharma Ltd is engaged in the business of marketing pharmaceutical critical care and health care products. The company provides a pharmaceutical formulation in therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, Orthopedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Pediatrics, Cardiology, Nephrology, Neurology, and others. It is also engaged in promoting and marketing Active Pharmaceuticals Ingredients (APIs) in India.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:542934 has been successfully added to your 